Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/NL-OMON26578
NL-OMON26578RecruitingNot Applicable

A phase 0 study to investigate the effects of inhaled and intranasal lipopolysaccharide (LPS) on pro-inflammatory markers sampled by hypertonic saline-induced sputum (SI) and nasal lavage (NAL) in healthy subjects. Part 1 with 0,9% NaCl.

QPS Netherlands B.V.QPS Netherlands BVPetrus Campersingel 1239713 AGGroningen0 sites10 target enrollmentStarted: TBDLast updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
10
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

/A

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • •1. Healthy Male/Female subjects, aged 18-55 yrs (inclusive);
  • •2. FVC, FEV1 80% ; FEV1/FVC ratio 0.75;

Exclusion Criteria

  • •1. History of upper and lower airway infection <4 wks;
  • •2. Relevant atopy;

Investigators

Sponsor
QPS Netherlands B.V.QPS Netherlands BVPetrus Campersingel 1239713 AGGroningen

Similar Trials

Completed
Not Applicable
A phase 0 study to investigate the effects of inhaled and intranasal lipopolysaccharide (LPS) on pro-inflammatory markers sampled by hypertonic saline sputum induction (SI) and nasal lavage (NAL) in healthy subjects. Part 1 with 0,9% NaCl.COPD10006436Asthma
NL-OMON36988QPS Netherlands B.V.10
Not yet recruiting
Unknown
Study to evaluate the effect of proper eating habits in treatment of aruchi disease
CTRI/2023/09/057627Shri Krishna Govt. Ayurvedic College and Hospital , Kurkshetra ,Haryana
Completed
Not Applicable
A study to detect the effect of radiofrequent ablation in combination with ipilimumab in patients with eye melanoma that spread out to the liver.uveal melanomaliver metastasesoog melanoomlever metastasen
NL-OMON26122KI-AV44
Completed
Phase 2
A phase II study of induction therapy using idarubicin and infusional high-dose cytarabine for adult patients with de novo untreated acute lymphoblastic leukaemiaacute lymphoblastic leukaemiaCancer - Leukaemia - Acute leukaemia
ACTRN12615000631505Australasian Leukaemia and Lymphoma Group20
Active, not recruiting
Not Applicable
A phase I-IIa clinical study on the investigational anticancer drug J1 in patients with advanced cancer. A prospective, single armed, open label, dose-finding phase I-IIa study.Treatment of cancer.MedDRA version: 8Level: HLTClassification code 10029105
EUCTR2005-002901-22-SEOncopeptides AB40